rosuwastatyna

Rosuastatyna is a selective inhibitor of the enzyme farnesyl pyrophosphate synthase (FPPS), which is crucial in the mevalonate pathway. This pathway is essential for the synthesis of cholesterol and other isoprenoids, which are important for cell membrane structure and function. Rosuvastatin, marketed under the brand name Crestor, is used primarily to lower cholesterol levels in the blood, particularly low-density lipoprotein (LDL) cholesterol, which is often referred to as "bad" cholesterol. By inhibiting FPPS, rosuvastatin reduces the production of cholesterol in the liver, thereby lowering LDL cholesterol levels. This drug is commonly prescribed to patients with high cholesterol levels, particularly those with a history of cardiovascular disease or those at high risk for developing it. Rosuvastatin is available in various dosages and is typically taken orally. It is important to note that rosuvastatin should be used under medical supervision, as it can have side effects such as muscle pain, liver enzyme elevation, and an increased risk of diabetes. Regular monitoring of liver function and blood sugar levels is often required during treatment.